Critical

Nerve agent / organophosphate mass exposure

cholinergic crisis antidote · Critical Care / ICU
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Nerve agents and organophosphates inhibit acetylcholinesterase, flooding synapses with acetylcholine and causing a cholinergic crisis. Rapid decontamination, atropine titrated to secretions, oximes, and seizure control are life-saving in a mass-exposure CBRN event.

Red flags

  • Copious bronchial secretions and bronchospasm (airway failure)
  • Seizures or coma
  • Profound bradycardia
  • Respiratory muscle weakness
  • Multiple simultaneous casualties with miosis and secretions (deliberate release)

Assessment

Differential diagnosis

  • Carbamate poisoning
  • Other cholinergic toxidrome
  • Status epilepticus of other cause
  • Opioid toxicity
  • Cyanide/asphyxiant exposure
  • Mass psychogenic illness

Investigations

  • Clinical toxidrome recognition (SLUDGE/DUMBELS, miosis, bronchorrhoea)
  • Red cell/plasma cholinesterase activity (confirmatory, not immediate)
  • Continuous ECG (bradycardia, QT changes)
  • ABG/oxygenation
  • Glucose and electrolytes
  • Agent identification via hazmat/public health

Management

  • Protect responders with appropriate PPE; do not become a secondary casualty
  • Remove the casualty from the source and perform decontamination (remove clothing, wash skin) before definitive treatment where possible
  • Secure the airway and provide high-flow oxygen; suction copious secretions
  • Give atropine and titrate rapidly to drying of bronchial secretions (the key endpoint), not pupil size or heart rate
  • Double the atropine dose every few minutes until secretions dry; large cumulative doses are often needed
  • Give an oxime (pralidoxime or obidoxime) to reactivate cholinesterase before ageing occurs
  • Control seizures and prevent them with a benzodiazepine (e.g. diazepam/midazolam); use auto-injectors in the field
  • Support ventilation for respiratory muscle failure
  • Manage mass casualties with triage, antidote auto-injectors, and surge capacity
  • Monitor for the intermediate syndrome (delayed weakness) and relapse
  • Coordinate with hazmat, public health, and law enforcement for a deliberate release
  • Continue atropine infusion and oxime as guided until the crisis resolves

Drugs & doses

Atropine 1.2-3 mg IV initial (2 mg in field auto-injectors), doubling every ~5 min until secretions dry
Pralidoxime 1-2 g IV over 15-30 min then infusion (or obidoxime per protocol)
Diazepam 5-10 mg IV or midazolam 10 mg IM for seizures/prophylaxis
Nerve-agent auto-injector (atropine + pralidoxime) in the field

Disposition

ICU with ventilatory support and atropine/oxime infusions; hazmat decontamination before hospital entry; public health and major-incident coordination.

Complications & pitfalls

  • Respiratory failure from bronchorrhoea and muscle paralysis
  • Intermediate syndrome (delayed proximal weakness)
  • Seizures and brain injury
  • Aspiration
  • Secondary responder contamination

Exam pearls

  • Atropine is titrated to drying secretions, not to heart rate or pupils, and huge doses may be required
  • Give the oxime early, before the enzyme ages and reactivation becomes impossible
  • Decontaminate to protect yourself and the department from secondary exposure
  • Benzodiazepines both treat and prevent nerve-agent seizures

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.